Previous studies in a neuroblastoma model indicate that the overexpression of CTCFL is related to a resistant phenotype, through the regulation of epigenetic processes70 and through the alteration of the ALK gene (whose downstream signal is the PI3K-Akt pathway as well)71. The gene discussed is ALK; the disease is neuroblastoma.